PCM
CPHR

Prelude Capital Management’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Prelude Capital Management’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,700
Closed -$34K – 2286
2015
Q1 		$34K Buy
3,700
+1,820
+97% +$22.9K ﹤0.01% 1627
2014
Q4 		$27K Buy
+1,880
New +$27.3K ﹤0.01% 1658

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

Prelude Capital Management's CPHR Position: Q2 2015 in Review

Prelude Capital Management sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q2 2015, closing a stake of 3,700 shares — an estimated $34K sold.

Prelude Capital Management first reported a position in CPHR in Q4 2014 and held it in 2 quarters. The position peaked at $34K in Q1 2015. 25 funds tracked by Wall St. Rank hold CPHR as of Q2 2015.

  • Prelude Capital Management reported no remaining Cipher Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Prelude Capital Management sold 3,700 Cipher Pharmaceuticals Inc. shares in Q2 2015, an estimated $34K.
  • Prelude Capital Management first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 2 quarters.
  • Prelude Capital Management's Cipher Pharmaceuticals Inc. position peaked at $34K in Q1 2015.
  • 25 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.